Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

News Daily News

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

October 10, 2024

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

News Daily News

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Michael O'Riordan

February 22, 2023

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

AHA Registry IDs Social Vulnerability as Risk Factor for COVID-19 Death

News Daily News

AHA Registry IDs Social Vulnerability as Risk Factor for COVID-19 Death

July 22, 2022

High Lp(a) May Predict Risk of CV and Limb Events in PAD

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

July 18, 2022

COVID-19: TCTMD’s Dispatch for June Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for June Week 4

June 20, 2022

TCTMD’s Top 10 Most Popular Stories for March 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2022

April 01, 2022

April 2022 News Roundup

News Opinion CV Team Dispatch

April 2022 News Roundup

April 01, 2022

March 2022 News Roundup

News Opinion CV Team Dispatch

March 2022 News Roundup

March 01, 2022

Even Less-Severe COVID-19 Can Have Long-term CV Effects

News Daily News

Even Less-Severe COVID-19 Can Have Long-term CV Effects

February 10, 2022

Consider COVID-19 History in Pre-op CV Screening, Doctors Say

News Daily News

Consider COVID-19 History in Pre-op CV Screening, Doctors Say

January 14, 2022

Discharge Safe as Early as a Day After Primary PCI for STEMI

News Daily News

Discharge Safe as Early as a Day After Primary PCI for STEMI

December 15, 2021

December 2021 News Roundup

News Opinion CV Team Dispatch

December 2021 News Roundup

December 01, 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

November 15, 2021

June 2021 News Roundup

News Opinion CV Team Dispatch

June 2021 News Roundup

June 01, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.